Genome surgery for eye disease moves closer to reality
Researchers have developed a CRISPR-based treatment that can restore retinal function in mice afflicted with retinitis pigmentosa, a degenerative eye disease. The 'ablate-and-replace' strategy allows for the precise removal and replacement of the faulty gene, enabling faster and less expensive treatment options for dominant disorders.